yingweiwo

Peptides

Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.

Peptides related products

Structure Cat No. Product Name CAS No. Product Description
KR-12 (human) V36546 KR-12 (human) KR-12 (human) is a peptide compound.
L-Alanyl-L-leucine V35575 L-Alanyl-L-leucine 3303-34-2 L-Alanyl-L-leucine is an endogenously produced metabolite.
L-Alanyl-L-tryptophan V35294 L-Alanyl-L-tryptophan 16305-75-2 L-Alanyl-L-tryptophan is a peptide compound.
L-Leucyl-L-Leucine methyl ester HBr V37101 L-Leucyl-L-Leucine methyl ester HBr 16689-14-8 L-Leucyl-L-Leucine methyl ester (LLOMe) HBr is a dipeptide condensation product of L-leucine methyl ester generated by human monocytes or polymorphonuclear leukocytes, which can selectively eliminate lymphocytes with cytotoxic potential.
Laminin Nonapeptide, amide V36536 Laminin Nonapeptide, amide 110590-61-9 Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 is a linear peptide developed from the laminin B1 chain that interferes with tumor cell attachment and invasion into the basement membrane and has anti-angiogenic effects.
LANREOTIDE V4355 LANREOTIDE 108736-35-2 Lanreotide (Ipstyl; Somatulin;BIM-23014; Lanreotide Autogel), a synthetic somatostatin analogue, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome.
LANREOTIDE ACETATE V4356 LANREOTIDE ACETATE 127984-74-1 Lanreotide acetate (BIM-23014;Ipstyl; BIM 23014; Somatulin), the acetate salt of lanreotide which is a synthetic somatostatin analogue, is an approved anticancer medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome.
LCKLSL V12565 LCKLSL 533902-29-3 LCKLSL is an N-terminal hexapeptide and a competitive annexin A2 (AnxA2) inhibitor that can effectively inhibit the binding of tissue plasminogen activator (tPA) to AnxA2.
Leiurotoxin I V35584 Leiurotoxin I 142948-19-4 Scyllatoxin (Leiurotoxin I) is a bioactive peptide toxin extracted from the venom of the scorpion (Leiurus quinquestriatus hebraeus).
Lepirudin V36502 Lepirudin 138068-37-8 Lepirudin is a potent irreversible thrombin inhibitor.
Leptin (138-167) (human) V36544 Leptin (138-167) (human) Leptin (138-167) (human) is a peptide compound.
Leptin (150-167) (human) V36545 Leptin (150-167) (human) 200436-46-0 Leptin (150-167) (human) is a peptide compound.
Leptin (93-105) (human) V36543 Leptin (93-105) (human) 200436-43-7 Leptin (93-105) is the 93-105 amino acid (AA) fragment of human leptin.
Leu-Enkephalin, amide V36743 Leu-Enkephalin, amide Leu-Enkephalin, amide is a peptide compound.
Leu-Gly|H-Leu-Gly-OH V37121 Leu-Gly|H-Leu-Gly-OH 686-50-0 H-Leu-Gly-OH is a glycine analogue.
Leu-Leu.HCl|H-Leu-Leu-OH.HCl V37107 Leu-Leu.HCl|H-Leu-Leu-OH.HCl 3303-31-9 Leu-Leu-OH is a Leu analogue, a dipeptide.
Leu-Ser-Lys-Leu V35586 Leu-Ser-Lys-Leu 162559-45-7 H-Leu-Ser-Lys-Leu-OH is a delay-related peptide located at the amino terminus of LAP and has an inhibitory activity against TGF-β1 activation.
Leu-Valorphin-Arg V34883 Leu-Valorphin-Arg 135861-77-7 Leu-Valorphin-Arg is a peptide compound.
Leucokinin III V35585 Leucokinin III 104958-71-6 Leucokinin III is a peptide compound.
LHRH V35587 LHRH 35263-73-1 LHRH, gonadotropin-releasing hormone, is a hypothalamic neuropeptide.
Contact Us